New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 26, 2014
07:46 EDTNBSNeoStem begins research collaboration for Scleroderma skin wound treatment
NeoStem announced that it has signed an agreement for a research collaboration investigating the potential of very small embryonic-like stem cells, or VSELs, in treating difficult to heal wounds in an animal model of scleroderma. The collaboration is funded in part by a previously announced $147,765 grant from the Small Business Innovative Research Program for the "Development of Adult Pluripotent Very Small Embryonic Like Stem Cells to Treat Skin Wounds in Scleroderma" from the National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases, or NIH-NIAMS. The study will employ the tight skin mouse to test the potential wound healing capabilities of autologous VSELs in treating difficult to heal skin ulcers characteristic of this disease. Depending on the results of the study, the company may qualify for up to an additional $1.5M phase 2 grant for the indication from NIH-NIAMS.
News For NBS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 20, 2015
07:33 EDTNBSNeoStem receives drug manufacture license for Irvine, CA facility
NeoStem announced that the State of California's Department of Public Health, Food and Drug Branch has completed its review of NeoStem's manufacturing and control processes at its Irvine, California cGMP facility for the production of eltrapuldencel-T and has issued NeoStem a manufacturing license permitting NeoStem to manufacture drugs from this facility, including the manufacture of eltrapuldencel-T for clinical trial use. Eltrapuldencel-T is the company's patient-specific targeted cancer immunotherapy under investigation for the treatment of Stage IV or recurrent Stage III metastatic melanoma.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use